Gangling Tong

839 total citations
29 papers, 458 citations indexed

About

Gangling Tong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gangling Tong has authored 29 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gangling Tong's work include Gastric Cancer Management and Outcomes (6 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Gangling Tong is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (5 papers). Gangling Tong collaborates with scholars based in China, Hong Kong and United States. Gangling Tong's co-authors include Boran Cheng, Shubin Wang, Xuan Wu, Yunsheng Xu, Yingying Lü, Feng Liu, Xiaolin Wang, Hong Peng, Feng Qiu and Zhihua Zheng and has published in prestigious journals such as Small, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Gangling Tong

28 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gangling Tong China 10 169 130 111 87 80 29 458
Lixia Zhu China 13 88 0.5× 113 0.9× 107 1.0× 108 1.2× 20 0.3× 54 427
Sina Salari Iran 12 55 0.3× 172 1.3× 97 0.9× 61 0.7× 65 0.8× 53 366
Michele Cennamo Italy 12 172 1.0× 187 1.4× 50 0.5× 21 0.2× 68 0.8× 27 534
Brenda J. Kitchen United States 10 77 0.5× 205 1.6× 86 0.8× 196 2.3× 46 0.6× 11 513
Francesco Taus Italy 9 108 0.6× 105 0.8× 50 0.5× 90 1.0× 19 0.2× 21 347
Martina Haberecker Switzerland 9 65 0.4× 84 0.6× 135 1.2× 53 0.6× 44 0.6× 29 319
Zuzana Paračková Czechia 13 166 1.0× 119 0.9× 66 0.6× 385 4.4× 10 0.1× 33 603
Ulrike Graubner Germany 14 43 0.3× 148 1.1× 140 1.3× 44 0.5× 27 0.3× 28 537
Zsolt Matula Hungary 10 88 0.5× 122 0.9× 65 0.6× 33 0.4× 43 0.5× 19 324
Clémence Hollande France 8 42 0.2× 64 0.5× 99 0.9× 84 1.0× 28 0.3× 20 355

Countries citing papers authored by Gangling Tong

Since Specialization
Citations

This map shows the geographic impact of Gangling Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangling Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangling Tong more than expected).

Fields of papers citing papers by Gangling Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gangling Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangling Tong. The network helps show where Gangling Tong may publish in the future.

Co-authorship network of co-authors of Gangling Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Gangling Tong. A scholar is included among the top collaborators of Gangling Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gangling Tong. Gangling Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Y., et al.. (2025). Hsa_circ_0002238 promotes the malignant behavior of colorectal cancer. Frontiers in Pharmacology. 16. 1541820–1541820. 1 indexed citations
4.
Li, Chen, Boran Cheng, Xiaodong Yang, et al.. (2023). SOX8 promotes tumor growth and metastasis through FZD6-dependent Wnt/β-catenin signaling in colorectal carcinoma. Heliyon. 9(12). e22586–e22586. 2 indexed citations
5.
Li, Zhu, Gangling Tong, Xiao-Dan Peng, & Shubin Wang. (2023). Circ_0005785 Silencing Constrains the Functional Properties of Colorectal Cancer Cells Depending on miR-7-5p/DNMT3A Axis. Biochemical Genetics. 62(3). 1795–1810. 2 indexed citations
6.
Yang, Yifan, et al.. (2023). IL23R as an indicator of immune infiltration and poor prognosis in intrahepatic cholangiocarcinoma: a bioinformatics analysis. Translational Cancer Research. 12(10). 2461–2476. 3 indexed citations
7.
Tong, Gangling, et al.. (2023). Risk Factors of Gastrointestinal Perforation with a Poor Prognosis. International Journal of General Medicine. Volume 16. 4637–4647. 6 indexed citations
8.
Zhu, Li, Gangling Tong, Xiao-Dan Peng, & Shubin Wang. (2023). Circ_0000370 Plays an Oncogenic Role in Colorectal Cancer by Regulating the miR-502-5p/SIRT1 Axis. Biochemical Genetics. 62(2). 1231–1247. 1 indexed citations
9.
Wu, Xuan, Boran Cheng, Gangling Tong, et al.. (2023). Immune activity score to assess the prognosis, immunotherapy and chemotherapy response in gastric cancer and experimental validation. PeerJ. 11. e16317–e16317. 4 indexed citations
10.
Tong, Gangling, et al.. (2022). circHIPK2 Has a Potentially Important Clinical Significance in Colorectal Cancer Progression via HSP90 Ubiquitination by miR485-5p. Critical Reviews in Eukaryotic Gene Expression. 32(8). 33–42. 7 indexed citations
11.
12.
Lü, Yingying, Feng Liu, Gangling Tong, et al.. (2021). Clinical evidence of an interferon–glucocorticoid therapeutic synergy in COVID-19. Signal Transduction and Targeted Therapy. 6(1). 107–107. 12 indexed citations
13.
Tong, Gangling, et al.. (2021). Retrospective Analyses of Complete Resection Combined with Systemic Chemotherapy and Targeted Therapy for Patients with Ovarian Metastases from Colorectal Cancer. Cancer Biotherapy and Radiopharmaceuticals. 37(7). 553–559. 2 indexed citations
14.
15.
Zhang, Mingying, et al.. (2021). Prognostic impact of sarcopenia on immune-related adverse events in malignancies received immune checkpoint inhibitors: a systematic review and meta-analysis. Translational Cancer Research. 10(12). 5150–5158. 10 indexed citations
17.
Tong, Gangling, Lin Lin, Li Wang, et al.. (2020). <p>Trastuzumab with FLOT Regimen for the Perioperative Treatment of Resectable HER2 + Advanced Gastric Cancer: A Retrospective Study</p>. Cancer Management and Research. Volume 12. 2481–2489. 6 indexed citations
18.
Wang, Nan, Yan Zhan, Linyu Zhu, et al.. (2020). Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients. Cell Host & Microbe. 28(3). 455–464.e2. 202 indexed citations
19.
Cheng, Boran, Gangling Tong, Xuan Wu, et al.. (2019). <p>Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer</p>. OncoTargets and Therapy. Volume 12. 7887–7896. 26 indexed citations
20.
Poon, Eileen, et al.. (2016). 498PD_PR Prevalence and types of distress among Adult and Young Adolescent (AYA) newly diagnosed with cancer in Singapore. Annals of Oncology. 27. ix161–ix161. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026